Novelion Therapeutics Inc. (NVLN) financial statements (2021 and earlier)

Company profile

Business Address C/O NORTON ROSE FULBRIGHT
VANCOUVER, BC V6B 0M3
State of Incorp. BC
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4555109142156119307
Cash and cash equivalents4555109142156119307
Restricted cash and investments 00    
Receivables292290054
Inventory, net of allowances, customer advances and progress billings131675  
Inventory131675    
Prepaid expense and other current assets1
Assets held-for-sale 0
Income taxes receivable01
Other undisclosed current assets1611(27)113949
Total current assets:103105166143157162363
Noncurrent Assets
Inventory, Noncurrent363459    
Property, plant and equipment2340123
Long-term investments and receivables   22  
Accounts and financing receivable, after allowance for credit loss   22  
Intangible assets, net (including goodwill)200225250  
Intangible assets, net (excluding goodwill)200225250    
Other noncurrent assets121   
Assets held-for-sale, long lived 0
Other undisclosed noncurrent assets     035
Total noncurrent assets:23926431523238
TOTAL ASSETS:342369481145160164401
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5056553549
Accounts payable614182236
Accrued liabilities4442372213
Employee-related liabilities    1  
Debt74      
Deferred compensation liability    00 
Estimated litigation liability  64    
Deferred revenue and credits     0
Other undisclosed current liabilities2879  (2)(0)2
Total current liabilities:4106411933411
Noncurrent Liabilities
Long-term debt and lease obligation 259226    
Long-term debt, excluding current maturities 259226    
Liabilities, other than long-term debt1110022
Liability for uncertainty in income taxes  00022
Other liabilities110    
Other undisclosed noncurrent liabilities1931     
Total noncurrent liabilities:202902260022
Total liabilities:43135434544613
Stockholders' equity
Stockholders' equity attributable to parent(89)15136141157158388
Common stock553552551475467466472
Additional paid in capital797369979896296
Accumulated other comprehensive income102104103103103103103
Accumulated deficit(822)(714)(587)(534)(511)(507)(482)
Total stockholders' equity:(89)15136141157158388
TOTAL LIABILITIES AND EQUITY:342369481145160164401

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues13013814    
Revenue, net13814    
Cost of revenue(60)(77)(6)  (1)(0)
Cost of goods and services sold(60)(77)(6)    
Gross profit:71618  (1)(0)
Operating expenses(121)(148)(44)(25)(31)(27)(55)
Other undisclosed operating income   228  
Operating loss:(50)(87)(37)(23)(4)(28)(55)
Nonoperating income (expense)(2)(0)(2)0(0)39
Foreign currency transaction gain (loss), before tax   0(0)(0)(0)
Other nonoperating income (expense)(2)(0)(2)0000
Interest and debt expense(4)      
Other undisclosed loss from continuing operations before equity method investments, income taxes  (14)    
Loss from continuing operations before equity method investments, income taxes:(56)(87)(52)(23)(4)(25)(46)
Other undisclosed loss from continuing operations before income taxes(50)(39)     
Loss from continuing operations before income taxes:(107)(126)(52)(23)(4)(25)(46)
Income tax expense (benefit)(2)(1)(0)(0)0(1)4
Loss from continuing operations:(108)(127)(53)(23)(4)(26)(42)
Income (loss) from discontinued operations    (0)188
Net income (loss):(108)(127)(53)(23)(4)(25)46
Other undisclosed net loss attributable to parent      (0)
Net income (loss) available to common stockholders, diluted:(108)(127)(53)(23)(4)(25)46

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(108)(127)(53)(23)(4)(25)46
Other comprehensive loss  (0)    
Comprehensive income (loss):(108)(127)(53)(23)(4)(25)46
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)1    (0)
Comprehensive income (loss), net of tax, attributable to parent:(110)(125)(53)(23)(4)(25)46

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: